These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16724185)

  • 21. Effects of progesterone stimulated allopregnanolone on craving and stress response in cocaine dependent men and women.
    Milivojevic V; Fox HC; Sofuoglu M; Covault J; Sinha R
    Psychoneuroendocrinology; 2016 Mar; 65():44-53. PubMed ID: 26716877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of pharmacokinetic and pharmacodynamic properties of isoallopregnanolone in healthy women.
    Hedström H; Bixo M; Nyberg S; Spigset O; Zingmark E; Bäckström T
    Psychopharmacology (Berl); 2009 Mar; 203(1):85-98. PubMed ID: 18949461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
    Martinez PE; Rubinow DR; Nieman LK; Koziol DE; Morrow AL; Schiller CE; Cintron D; Thompson KD; Khine KK; Schmidt PJ
    Neuropsychopharmacology; 2016 Mar; 41(4):1093-102. PubMed ID: 26272051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allopregnanolone levels and symptom improvement in severe premenstrual syndrome.
    Freeman EW; Frye CA; Rickels K; Martin PA; Smith SS
    J Clin Psychopharmacol; 2002 Oct; 22(5):516-20. PubMed ID: 12352277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Women with acute intermittent porphyria have a defect in 5α-steroid production during the menstrual cycle.
    Innala E; Bäckström T; Poromaa IS; Andersson C; Bixo M
    Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1445-52. PubMed ID: 22924787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral progesterone decreases saccadic eye velocity and increases sedation in women.
    van Broekhoven F; Bäckström T; Verkes RJ
    Psychoneuroendocrinology; 2006 Nov; 31(10):1190-9. PubMed ID: 17034954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences.
    Genazzani AR; Petraglia F; Bernardi F; Casarosa E; Salvestroni C; Tonetti A; Nappi RE; Luisi S; Palumbo M; Purdy RH; Luisi M
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2099-103. PubMed ID: 9626145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allopregnanolone has no effect on startle response and prepulse inhibition of startle response in patients with premenstrual dysphoric disorder or healthy controls.
    Kask K; Bäckström T; Lundgren P; Sundström Poromaa I
    Pharmacol Biochem Behav; 2009 Jun; 92(4):608-13. PubMed ID: 19268499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low serum allopregnanolone is associated with symptoms of depression in late pregnancy.
    Hellgren C; Åkerud H; Skalkidou A; Bäckström T; Sundström-Poromaa I
    Neuropsychobiology; 2014; 69(3):147-53. PubMed ID: 24776841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone.
    Hargrove JT; Maxson WS; Wentz AC; Burnett LS
    Obstet Gynecol; 1989 Apr; 73(4):606-12. PubMed ID: 2538787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse mood effects during postmenopausal hormone treatment in relation to personality traits.
    Björn I; Bäckström T; Lalos A; Sundström-Poromaa I
    Climacteric; 2006 Aug; 9(4):290-7. PubMed ID: 16857659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial.
    Lacut K; Oger E; Abalain JH; Moineau MP; Mottier D;
    Atherosclerosis; 2004 May; 174(1):173-80. PubMed ID: 15135267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of 3-year treatment with 0.25 mg/day of micronized 17beta-estradiol on cognitive function in older postmenopausal women.
    Pefanco MA; Kenny AM; Kaplan RF; Kuchel G; Walsh S; Kleppinger A; Prestwood K
    J Am Geriatr Soc; 2007 Mar; 55(3):426-31. PubMed ID: 17341247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum allopregnanolone in women with postpartum "blues".
    Nappi RE; Petraglia F; Luisi S; Polatti F; Farina C; Genazzani AR
    Obstet Gynecol; 2001 Jan; 97(1):77-80. PubMed ID: 11152912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allopregnanolone impairs episodic memory in healthy women.
    Kask K; Bäckström T; Nilsson LG; Sundström-Poromaa I
    Psychopharmacology (Berl); 2008 Aug; 199(2):161-8. PubMed ID: 18551282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of acute progesterone administration in healthy postmenopausal women and normally-cycling women.
    de Wit H; Schmitt L; Purdy R; Hauger R
    Psychoneuroendocrinology; 2001 Oct; 26(7):697-710. PubMed ID: 11500251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-year therapy with 10mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu.
    Pluchino N; Ninni F; Stomati M; Freschi L; Casarosa E; Valentino V; Luisi S; Genazzani AD; Potì E; Genazzani AR
    Maturitas; 2008 Apr; 59(4):293-303. PubMed ID: 18394829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individual differences in changes in mood and platelet monoamine oxidase (MAO) activity during hormonal replacement therapy in menopausal women.
    Klaiber EL; Broverman DM; Vogel W; Peterson LG; Snyder MB
    Psychoneuroendocrinology; 1996 Oct; 21(7):575-92. PubMed ID: 9044441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Moderate doses of ethanol fail to increase plasma levels of neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one-like immunoreactivity in healthy men and women.
    Holdstock L; Penland SN; Morrow AL; de Wit H
    Psychopharmacology (Berl); 2006 Jun; 186(3):442-50. PubMed ID: 16240164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.